Sfoglia per AUTORE
ECKHARDT K
Collezione AOU Città della Salute di Torino
Items : 1
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13). in EClinicalMedicine / EClinicalMedicine. 2023 Sep 22;64:102221. doi: 10.1016/j.eclinm.2023.102221. eCollection 2023 Oct.
2023
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Gadient S; Scheibe B; Dirnhofer S; Menter T; Ivanova VS; Cairoli A; Voegeli M; Böttcher S; Mach N; Boccomini C; Ferrero S; Mey U; Hess G; Zander T; Derenzini E; Schmidt C; Dreyling M; Schär S; Fehr M; Novak U; Eckhardt K; Zucca E; Driessen C; Renner C;